new concerns about cardiac risk with Meridia

See updated information from FDA and Health Canada concerning the withdrawal of Meridia from the U.S. and Canadian markets

You'll hear new concerns about cardiac risk with Meridia.

The manufacturer tried to show that Meridia (sibutramine) could improve cardiovascular outcomes in high-risk patients...by helping them lose weight.

But instead they found a HIGHER risk of heart attacks and strokes in patients taking Meridia.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote